STUDIES ON THE ABSTINENCE-LIKE OVERSHOOT FOLLOWING REVERSAL OF THE POTENT 19-ISOAMYL DERIVATIVE OF ETORPHINE WITH NALOXONE - A COMPARISON WITH THE OPIOIDS FENTANYL AND ALFENTANIL
E. Freye et al., STUDIES ON THE ABSTINENCE-LIKE OVERSHOOT FOLLOWING REVERSAL OF THE POTENT 19-ISOAMYL DERIVATIVE OF ETORPHINE WITH NALOXONE - A COMPARISON WITH THE OPIOIDS FENTANYL AND ALFENTANIL, Arzneimittel-Forschung, 47(1), 1997, pp. 6-9
Reversal of opioid-related respiratory depression is often accompanied
by an ''acute abstinence like syndrome'' with hypertension, tachycard
ia, and pain. This overshoot was used to investigate the extent at whi
ch opioids of high potency but different structure are involved in nal
oxone-induced abstinence In 10 awake and trained mongrel dogs two high
ly mu-selective compounds, alfentanil and fentanyl, were given in cumu
lative doses and at different occasions (30-60-120-240 mu g/kg, and 6-
12-24-48 mu g/kg, respectively). Subsequently, a high dose of naloxone
(100 mu g/kg) was given at 5 min intervals while arterial blood gases
, blued pressure. heart rate and the somatosensory evoked potential (S
EP) were measured continuously. Following a wash-out period. the 19-is
oamyl derivative of etorphine (M-140 10,000 times more potent than nor
morphine and a 4.5 fold potency of ethylketocyclazocine in a bioessay
preparation) was also given in increasing doses (0.2-0.4-0.5-3.2 mu g/
kg). Again, naloxone was given (100 mu g/kg) at 5 min interval, while
cardiovascular parameters, blood gases and SEPs were measured continuo
usly. All three opioids induced a dose-related respiratory depression
with hypercarbia and hypoxia, a dose-related bradycardia, and a modest
hypotension. This was accompanied by a dose-related depression of the
amplitude of the SEP, reflecting the degree of blockade of nociceptiv
e afferents. Naloxone was sufficient to reverse respiratory impairment
after fentanyl, alfentanil and M-140. However, in contrast to fentany
l and alfentanil, there: was no cardiovascular or evoked potential ove
rshoot following naloxone reversal of M-140. After alfentanil naloxone
increased blood pressure. heart rate and amplitude of the SEP by, 7 %
, 41 %, and 38 %, respectively. After fentanyl this increase in blood
pressure, heart rate and amplitude of the SEP was 17 %, 43 % and 96 %,
respectively. The study indicates that the more potent the opiate mu
ligands are the more is naloxone liable to Induce a hyperexcitatory st
ate of the cardiovascular system and an increase of nociceptive stimul
i to pain modulating centres. After M-140 reversal of mu-related respi
ratory depression by naloxone was possible. However, no precipitation
on an acute abstinence-like syndrome affecting antinociception or indu
cing cardiovascular overshoot was observed. This may stem from an inte
nse binding and slow dissociation of the ligand from the receptor site
or may be due to a high binding affinity to both the mu and the kappa
receptor site. Opioids which interact with various receptor sites may
be of clinical interest for substitution therapy in opioid dependent
addicts.